Comparative study between intrathecal dexmedetomidine versus intrathecal magnesium sulfate in prevention of post spinal shivering in uroscopic surger

Comparative study between intrathecal dexmedetomidine versus intrathecal magnesium sulfate in prevention of post spinal shivering in uroscopic surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201801003001727

Enrollment

105

Registered

2018-01-23

Start date

2017-09-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Urological and Genital Diseases post spinal shivering

Interventions

normal saline

magnesium sulfate

dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Uroscopic surgeries. 2) ASA I and II. 3) Age 20-60years old.

Exclusion criteria

Exclusion criteria: 1) Patient refusal. 2) Contraindication to spinal anesthesia e.g; coagulopathy. 3) ASA III- IV. 4) Neurological diseases e.g.; Parkinson¿s disease, Dysautonomia. 5) Endocrine diseases except diabetes mellitus.

Design outcomes

Primary

Measure	Time frame
Incidence and intensity of shivering	—

Secondary

Measure	Time frame
1) Use of pethidine in case of occurrences of shivering.	—

Countries

Egypt

Contacts

Public ContactHeba Omar

lecturer of anesthesia, faculty of medicine, Cairo university

hebaomar2@yahoo.com01128102222

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026